BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xie Y, Xie F, Zhang L, Zhou X, Huang J, Wang F, Jin J, Zhang L, Zeng L, Zhou F. Targeted Anti-Tumor Immunotherapy Using Tumor Infiltrating Cells. Adv Sci (Weinh) 2021;8:e2101672. [PMID: 34658167 DOI: 10.1002/advs.202101672] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Chang K, Xu F, Zhang X, Zeng B, Zhang W, Shi G, Ye D. Construction of an Immune Escape-Related Signature in Clear Cell Renal Cell Carcinoma and Identification of the Relationship between IFNAR1 and Immune Infiltration by Multiple Immunohistochemistry. Cancers (Basel) 2022;15. [PMID: 36612165 DOI: 10.3390/cancers15010169] [Reference Citation Analysis]
2 Lu C, Schardey J, Wirth U, von Ehrlich-Treuenstätt V, Neumann J, Gießen-Jung C, Werner J, Bazhin AV, Kühn F. Analysis of Circulating Immune Subsets in Primary Colorectal Cancer. Cancers (Basel) 2022;14. [PMID: 36551592 DOI: 10.3390/cancers14246105] [Reference Citation Analysis]
3 Deng J, Xu W, Lei S, Li W, Li Q, Li K, Lyu J, Wang J, Wang Z. Activated Natural Killer Cells-Dependent Dendritic Cells Recruitment and Maturation by Responsive Nanogels for Targeting Pancreatic Cancer Immunotherapy. Small 2022;18:e2203114. [PMID: 36148846 DOI: 10.1002/smll.202203114] [Reference Citation Analysis]
4 Schirrmacher V, van Gool S, Stuecker W. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy. IJMS 2022;23:13050. [DOI: 10.3390/ijms232113050] [Reference Citation Analysis]
5 Yang J, Ye H, Fan X, Li Y, Wu X, Zhao M, Hu Q, Ye Y, Wu L, Li Z, Zhang X, Liang C, Wang Y, Xu Y, Li Q, Yao S, You D, Zhao K, Liu Z. Artificial intelligence for quantifying immune infiltrates interacting with stroma in colorectal cancer. J Transl Med 2022;20:451. [PMID: 36195956 DOI: 10.1186/s12967-022-03666-3] [Reference Citation Analysis]
6 Tian R, Sun Y, Han X, Wang J, Gu H, Wang W, Liang L. Identification and validation of prognostic autophagy-related genes associated with immune microenvironment in human gastric cancer. Aging (Albany NY) 2022;14:7617-34. [PMID: 36173625 DOI: 10.18632/aging.204313] [Reference Citation Analysis]
7 Chen X, Chen DR, Liu H, Yang L, Zhang Y, Bu LL, Sun ZJ, Cai L. Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma. J Control Release 2022;351:381-93. [PMID: 36096364 DOI: 10.1016/j.jconrel.2022.09.010] [Reference Citation Analysis]
8 Hassanian H, Asadzadeh Z, Baghbanzadeh A, Derakhshani A, Dufour A, Rostami Khosroshahi N, Najafi S, Brunetti O, Silvestris N, Baradaran B. The expression pattern of Immune checkpoints after chemo/radiotherapy in the tumor microenvironment. Front Immunol 2022;13:938063. [DOI: 10.3389/fimmu.2022.938063] [Reference Citation Analysis]
9 Hu W, Liu D, Li R, Qian H, Qiu W, Ye Q, Kong F. Comprehensive Analysis of TRIM Family Genes in Hepatitis Virus B-Related Hepatoma Carcinoma. Front Genet 2022;13:913743. [DOI: 10.3389/fgene.2022.913743] [Reference Citation Analysis]
10 You W, Ma F, Zhang Z, Yan J. Turning a Targeting β-Catenin/Bcl9 Peptide Inhibitor into a GdOF@Au Core/Shell Nanoflower for Enhancing Immune Response to Cancer Therapy in Combination with Immune Checkpoint Inhibitors. Pharmaceutics 2022;14:1306. [PMID: 35745877 DOI: 10.3390/pharmaceutics14061306] [Reference Citation Analysis]
11 Wang W, Guo MN, Li N, Pang DQ, Wu JH. Glutamine deprivation impairs function of infiltrating CD8+ T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis. World J Gastrointest Oncol 2022; 14(6): 1124-1140 [DOI: 10.4251/wjgo.v14.i6.1124] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Lai G, Li K, Deng J, Liu H, Xie B, Zhong X, Srinivasan K. Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors. Journal of Healthcare Engineering 2022;2022:1-17. [DOI: 10.1155/2022/8704127] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Sun F, Lian Y, Wang J, Hu L, Luo J, Yu J, Wang J. KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4829697] [Reference Citation Analysis]
14 Xing J, Chen M, Han Y. . MBE 2022;19:5905-24. [DOI: 10.3934/mbe.2022276] [Cited by in F6Publishing: 1] [Reference Citation Analysis]